Literature DB >> 3225331

EBM/11 reactivity in malignant histiocytosis.

P M Kelly1, M McGovern, K C Gatter, J M Theaker, J O McGee.   

Abstract

A patient presented initially with a testicular mass, which on biopsy had morphological features consistent with malignant histiocytosis. The tumour cells labelled strongly with EBM/11, a murine monoclonal antibody with high specificity for cells of the human mononuclear phagocyte system. Subsequent clinical and laboratory studies confirmed the diagnosis. As poorly differentiated tumour cells reacted with EBM/11, this antibody may be useful in positively identifying malignant tumours with histiocytic differentiation from malignancies of other types where morphological detail alone is inconclusive in tumour classification.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3225331      PMCID: PMC1141764          DOI: 10.1136/jcp.41.12.1305

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopatholigic study of 29 cases.

Authors:  R A Warnke; H Kim; R F Dorfman
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

2.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

3.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

4.  Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

Authors:  P C Beverley; R E Callard
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

Review 5.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

6.  Relationship of lysozyme (muramidase) to histiocytic differentiation in malignant histocytosis: an immunohistochemical study.

Authors:  G Mendelsohn; J C Eggleston; R B Mann
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

7.  Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.

Authors:  E S Jaffe; J A Strauchen; C W Berard
Journal:  Am J Clin Pathol       Date:  1982-01       Impact factor: 2.493

8.  Malignant lymphoma of true histiocytic origin: histiocytic sarcoma. A morphological, ultrastructural, immunological, cytochemical and clinical study of 10 cases.

Authors:  P van der Valk; J te Velde; J Jansen; D J Ruiter; P J Spaander; C J Cornelisse; C J Meijer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study.

Authors:  E Tahara; H Ito; F Shimamoto; T Iwamoto; K Nakagami; H Niimoto
Journal:  Histopathology       Date:  1982-07       Impact factor: 5.087

10.  Immunohistochemical differentiation between histiocytic and lymphoid neoplasms.

Authors:  P G Isaacson; D B Jones
Journal:  Histochem J       Date:  1983-07
View more
  2 in total

1.  Growth factor (M-CSF) and antigenic properties of macrophages in meningioma.

Authors:  B Giometto; F Bozza; P Gallo; S Pagni; V Argentiero; S Ferla; S Mingrino; B Tavolato
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

2.  Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.

Authors:  R A Warnke; K A Pulford; G Pallesen; E Ralfkiaer; D C Brown; K C Gatter; D Y Mason
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.